HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrich J Sachs Selected Research

Neonatal Alloimmune Thrombocytopenia

1/2022Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?
2/2020Prospects for risk stratification of anti-HPA-1a alloimmunized pregnant women.
1/2020Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
1/2020Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
11/2019Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
1/2017HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
1/2016A bead-based assay in the work-up of suspected platelet alloimmunization.
1/2016Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
12/2015Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
6/2015Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulrich J Sachs Research Topics

Disease

19Thrombocytopenia (Thrombopenia)
01/2022 - 11/2011
15Neonatal Alloimmune Thrombocytopenia
01/2022 - 11/2011
9Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2021 - 01/2010
8Hemorrhage
08/2022 - 12/2013
8Transfusion-Related Acute Lung Injury
10/2021 - 12/2003
4Neutropenia
01/2021 - 01/2013
2COVID-19
01/2021 - 01/2021
2Infections
01/2021 - 12/2020
2Transfusion Reaction
01/2016 - 12/2009
2Thrombosis (Thrombus)
06/2013 - 04/2013
1Hemophilia A (Haemophilia)
08/2022
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
04/2022
1Lung Injury
10/2021
1Glomerulonephritis
01/2021
1Intellectual Disability (Idiocy)
12/2020
1Periodontitis
12/2020
1Skin Diseases (Skin Disease)
12/2020
1Birth Weight (Birth Weights)
01/2020
1Chickenpox
01/2019
1Malaria
01/2018
1Thymoma (Thymic Carcinoma)
11/2017
1Thrombasthenia (Glanzmann Thrombasthenia)
01/2016
1Inflammation (Inflammations)
11/2015
1Pyogenic arthritis, pyoderma gangrenosum, and acne
11/2015
1hyperzincemia and hypercalprotectinemia
11/2015
1Body Weight (Weight, Body)
06/2015
1Transient Ischemic Attack
01/2014
1Thromboembolism
06/2013
1Protein S Deficiency (Deficiency, Protein S)
06/2013
1Protein C Deficiency
06/2013
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2013
1Neoplasms (Cancer)
10/2005

Drug/Important Bio-Agent (IBA)

20AntibodiesIBA
01/2022 - 12/2003
10IsoantibodiesIBA
01/2021 - 11/2011
7Heparin (Liquaemin)FDA LinkGeneric
12/2021 - 12/2011
7AntigensIBA
10/2021 - 11/2011
6AutoantibodiesIBA
01/2021 - 02/2012
5VaccinesIBA
12/2021 - 01/2021
5Human Platelet AntigensIBA
11/2019 - 07/2013
5Inosine Triphosphate (ITP)IBA
08/2019 - 02/2012
4ChAdOx1 nCoV-19IBA
12/2021 - 01/2021
4Glycoproteins (Glycoprotein)IBA
01/2021 - 11/2011
3human ITGB3 protein (HPA-1a)IBA
11/2019 - 11/2011
3Immunoglobulin G (IgG)IBA
01/2018 - 12/2013
2COVID-19 VaccinesIBA
12/2021 - 01/2021
2Platelet Factor 4IBA
12/2021 - 01/2014
2Proteins (Proteins, Gene)FDA Link
10/2021 - 11/2015
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 01/2020
2Member 2 Protein Solute Carrier Family 44IBA
07/2015 - 11/2013
1Blood Coagulation Factors (Coagulation Factor)IBA
08/2022
1Vitamin KFDA Link
04/2022
1AnticoagulantsIBA
04/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1FucoseIBA
12/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2020
1PiperacillinFDA LinkGeneric
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1LigandsIBA
01/2018
1Sunitinib (Sutent)FDA Link
11/2017
1HLA-DRB3 Chains (HLA DRB3)IBA
01/2017
1IntegrinsIBA
01/2016
1Proline (L-Proline)FDA Link
11/2015
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
11/2015
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
11/2015
1PyrinIBA
11/2015
1AlarminsIBA
11/2015
1von Willebrand FactorIBA
07/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2015
1Oxidoreductases (Dehydrogenase)IBA
11/2013
1NADP (NADPH)IBA
11/2013
1AlbuminsIBA
11/2013
1LipopolysaccharidesIBA
11/2013
1Monoclonal AntibodiesIBA
07/2013
1Antiphospholipid AntibodiesIBA
06/2013
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
06/2013
1Prothrombin (Factor II)IBA
06/2013
1factor V LeidenIBA
06/2013
1AntithrombinsIBA
06/2013
1Protamines (Protamine Sulfate)FDA Link
04/2013
1Platelet Membrane Glycoprotein IIbIBA
11/2011
1Junctional Adhesion Molecule CIBA
10/2005

Therapy/Procedure

2Therapeutics
12/2020 - 01/2010
1Blood Transfusion (Blood Transfusions)
10/2021
1General Anesthesia
12/2020
1Blood Component Removal (Apheresis)
06/2015